Source: Virtual Congress 2021 – COVID - 19 epidemiology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Etel (Shropshire, United Kingdom), T. Chapman (Staffordshire, United Kingdom), H. Moudgil (Shropshire, United Kingdom), K. Srinivasan (Shropshire, United Kingdom), A. Makan (Shropshire, United Kingdom), E. Crawford (Shropshire, United Kingdom), N. Ahmad (Shropshire, United Kingdom). Impact of COVID-19 on patients with chronic lung disease. 3265

Member's Comments

No comment yet.

Related content which might interest you: Functional status in patients with chronic lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 652s Year: 2007 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Prediction of chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 139s Year: 2003 Study of lung functions in patients of chronic liver disease. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Quality control of lung function testing in the registry for patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Lung function II Year: 2007 Distribution of severity of patients with obstructive lung disease in an at risk population Source: Eur Respir J 2004; 24: Suppl. 48, 474s Year: 2004 Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Post-surgery complications in patients with chronic lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006 Impact of exacerbation on health status deterioration in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001 The impact of COVID-19 on children with chronic suppurative lung disease Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation Year: 2021 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Psychological outcomes from pulmonary rehabilitation in patients with chronic obstructive lung disease Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more? Year: 2010 Chronic interstitial lung disease in children Source: Eur Respir Rev, 27 (147) 170100; 10.1183/16000617.0100-2017 Year: 2018 Chronic interstitial lung disease in children Source: International Congress 2017 – Paediatric year in review: update on paediatric pulmonology Year: 2017 PP310 – Association of testosterone with lung function in patients with chronic obstructive lung disease Source: ERS Lung Science Conference 2021 Year: 2021 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 The impact of anemia of chronic disease on exercise capacity among patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019